Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10307429
APP PUB NO 20180000845A1
SERIAL NO

15380219

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are stable complexes with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound Celecoxib, its salts, or derivatives thereof, which is useful in the treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain especially in cancer related acute pain, primary dysmenorrhea. More specifically, the complexes possess instantaneous redispersibility, increased apparent solubility and permeability that provide faster onset of action for acute pain relief and lower GI related side effects. Further disclosed are methods of formulating and manufacturing the complexes described herein, pharmaceutical compositions, and uses and methods of treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAVANTA THERAPEUTICS HUNGARY INCORPORATED1138 BUDAPEST

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ötvös, Zsolt Csongrád, HU 21 55
Angi, Erzsébet Réka Nagykovácsi, HU 12 19
Basa-Dénes, Orsolya Eger, HU 15 21
Filipcsei, Genovéva Budapest, HU 28 46
Glavinas, Hristos Szeged, HU 27 36
Jordán, Tamás Öcsöd, HU 14 18
Kárpáti, Richárd Balázs Tatabánya, HU 16 16
Molnár, László Biatorbágy, HU 12 45
Patyi, Gergo Vecsés, HU 9 10
Solymosi, Tamás Békéscsaba, HU 17 22

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 4, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 4, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00